Legislators
Bills
Statements
Lobbying
Travel
Searching...- Bills
- S.1428
S.1428: Preserve Access to Affordable Generics and Biosimilars Act
About This Bill
- This bill was introduced in the 117th Congress
- This bill is primarily about health
- Introduced April 28, 2021
- Latest Major Action Dec. 9, 2021
- See the two similar bills introduced in other congresses.
Bill Sponsor
Bill Cosponsors
12 (7 Democrats, 5 Republicans)
Bill Versions
- Reported to Senate - Dec. 9, 2021
- Introduced in Senate - April 28, 2021
Bill Summary
Preserve Access to Affordable Generics and Biosimilars Act This bill authorizes the Federal Trade Commission (FTC) to initiate proceedings against parties to any agreement resolving or settling a patent infringement claim in connection with the sale of a drug or biological product. Such an agreement is presumed to have anticompetitive effects and is a violation of this bill if the filer of the generic drug or biosimilar application receives...
(Source: Library of Congress)
What Lawmakers Are Saying About This Bill
Bill Actions
| Date | Description |
|---|---|
| Dec. 9, 2021 |
Placed on Senate Legislative Calendar under General Orders. Calendar No. 180.
|
| Dec. 9, 2021 |
Committee on the Judiciary. Reported by Senator Durbin with an amendment in the nature of a substitute. Without written report.
|
| July 29, 2021 |
Committee on the Judiciary. Ordered to be reported with an amendment in the nature of a substitute favorably.
|
| April 28, 2021 |
Read twice and referred to the Committee on the Judiciary.
|
| April 28, 2021 |
Introduced in the Senate by Amy Klobuchar (D-Minn.) |